Flow Cytometry
J15 · Effective Oct 1, 2015
11 active Medicare policies list D47.2, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Aug 1, 2022
JK · Effective Aug 1, 2022
National · Effective Mar 5, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D47.2 |
|---|---|---|
| Bortezomib Products | Feb 2, 2024 | Covered |
| Hematopoietic Cell Transplantation for Multiple Myeloma | Dec 13, 2023 | Covered |
| Positron Emission Tomography (PET) | Sep 21, 2023 | Covered |
| Policy | Effective | Status of D47.2 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
J6 · Effective Apr 1, 2026
| Policy | Effective | Status of D47.2 |
|---|
| Flow Cytometry | Sep 15, 2026 | Covered |
|---|